Page 2 - Les meilleurs Chimiothérapie en Israël pour votre Chimiothérapie - TOP 32 des médecins

Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.

She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.

Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.

Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.

He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.

He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.

He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.

He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.

Prof. Elad Jacoby, MD, heads the Pediatric Cell Therapy Center at Sheba Medical Center. He is the Medical Director of the Advanced Biotherapy Center. He is a pioneer of pediatric CAR T‑cell therapy in Israel. He led one of the first national leukemia programs. He has almost 20 years of clinical and research experience.

He specializes in CAR T‑cell therapy, bone marrow and stem cell transplantation, and high‑risk pediatric leukemias and lymphomas. He leads international clinical trials and has authored over 240 publications. His collaborations include Johns Hopkins Hospital and the U.S. National Cancer Institute. He is an Associate Professor at Tel Aviv University. He received his MD from Tel Aviv University, completed residency at Sheba Medical Center, and fellowships at Johns Hopkins and the National Cancer Institute. He is board‑certified in Pediatrics and in Pediatric Hematology and Oncology. He serves on the IBFM CAR T‑Cell Taskforce and the Sheba Institutional Review Board. He leads the integration of CAR T‑cell therapy with transplantation.

Spécialiste israélien de premier plan en immunothérapie du cancer du poumon – le Prof. Peled dirige l'Unité des cancers thoraciques au Centre de cancérologie Davidoff.

• Formation de fellowship en cancer du poumon à l'Université du Colorado à Denver
• Récipiendaire du prix MERIT de l'American Society of Clinical Oncology (ASCO)
• Préside le Comité de détection précoce et de prévention de l'IASLC
• Spécialisé en médecine personnalisée et en immuno-oncologie pour le cancer du poumon

Expert internationalement reconnu en oncologie pédiatrique – le Prof. Ben-Harush dirige la Division de Pédiatrie à l'Hôpital pour enfants Ruth Rappaport.

• Spécialisé en oncologie pédiatrique et en transplantation de moelle osseuse
• Récipiendaire du titre de Chevalier de la Légion d'Honneur en France
• Nommé l'un des médecins les plus attentionnés au monde par l'Association Médicale Mondiale
• Membre de groupes d'oncologie pédiatrique aux États-Unis et en Europe

Spécialiste en radiothérapie, se concentrant spécifiquement sur l'oncologie au Centre médical Rambam.

• Se spécialise dans les traitements de chimiothérapie et de radiothérapie
• Travaille au Centre médical Rambam, un établissement de santé de premier plan
• S'engage à proposer des plans de soins oncologiques personnalisés

Directeur/Directrice du Centre de traitement du cancer du sein – Le/La Professeur(e) Jablonski-Perec apporte des décennies d'expertise spécialisée au Centre médical Hadassah.

• Formation médicale reçue au Sloan-Kettering Cancer Center de New York
• Professeur(e) d'oncologie à l'Université hébraïque depuis 2006
• Ancien/Ancienne directeur(trice) de l'Institut d'oncologie
• Membre de multiples sociétés internationales d'oncologie

Le Dr Spielberg est un onco-hématologue spécialisé qui traite des patients au Centre Médical Assuta.

• Se concentre exclusivement sur les traitements de chimiothérapie
• Travaille dans l'un des principaux centres médicaux d'Israël
• Dédié à l'élaboration de plans de traitement personnalisés pour chaque patient

Le Dr Zhevelyuk est spécialisé en oncologie et en radiologie à l'Assuta Medical Center.

• Expérimenté dans les traitements de chimiothérapie
• Travaille dans un centre médical de premier plan
• Se concentre sur les soins centrés sur le patient

Médecin-chef du Centre d'oncologie à l'Assuta Medical Center – expert de premier plan en traitements de chimiothérapie.

• Spécialisé en oncologie avec une vaste expérience des protocoles de chimiothérapie
• Occupe un rôle de leadership dans un centre médical de haut niveau
• Dédié aux plans de traitement personnalisés pour chaque patient